Rhumbline Advisers Volitionrx LTD Transaction History

Rhumbline Advisers

  • $103 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021
SELL
$3.01 - $3.78 $56,928 - $71,491
-18,913 Closed
0 $0
Q1 2021

May 06, 2021
BUY
$3.33 - $6.5 $3,746 - $7,312
1,125 Added 6.32%
18,913 $71,000
Q4 2020

Feb 10, 2021
BUY
$2.88 - $4.33 $6,341 - $9,534
2,202 Added 14.13%
17,788 $69,000
Q3 2020

Nov 12, 2020
SELL
$2.94 - $4.05 $18,727 - $25,798
-6,370 Reduced 29.01%
15,586 $50,000
Q2 2020

Aug 13, 2020
BUY
$2.89 - $4.32 $63,452 - $94,849
21,956 New
21,956 $85,000

Others Institutions Holding VNRX

# of Institutions
27
Shares Held
7.96M
Call Options Held
39K
Put Options Held
0
View Full List

About VOLITIONRX LTD

VNRX Quotes by TradingView
  • Ticker VNRX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 57,297,000
  • Market Cap $35M
  • Description
  • VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...
More about VNRX
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email